Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 25
«Preious | of 5 |
1

An assessment of statin safety by hepatologists

DRUG EVALUATION, Volume 4, Issue 2,2007, Pages 82-84,90, doi:10.3969/j.issn.1672-2809.2007.02.007

2

Thought about diagnoses and therapy of non-alcoholic fatty liver disease

DRUG EVALUATION, Volume 4, Issue 2,2007, Pages 95-98, doi:10.3969/j.issn.1672-2809.2007.02.012

3

Treatment of non-alcoholic fatty liver disease with traditional chinese medicine

DRUG EVALUATION, Volume 4, Issue 2,2007, Pages 93-95, doi:10.3969/j.issn.1672-2809.2007.02.011

4

The diagnoses and therapy of chronic hepatitis c with fatty liver disease

DRUG EVALUATION, Volume 4, Issue 2,2007, Pages 88-90, doi:10.3969/j.issn.1672-2809.2007.02.009

5

非酒精性脂肪性肝病诊疗指南

DRUG EVALUATION, Volume 4, Issue 2,2007, Pages 77-79, doi:10.3969/j.issn.1672-2809.2007.02.005

Items 1-5 of 25
«Preious | of 5 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn